LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ:KEQU) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ:KEQU) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ:KEQU) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / August 14, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ: KEQU ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ:KEQU) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ: KEQU ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ: KEQU ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kewaunee Scientific Corporation ("Kewaunee Scientific" or "the Company") (NASDAQ:KEQU) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
PHILADELPHIA, PA / ACCESSWIRE / August 6, 2024 / Kaskela Law LLC announces that it is investigating Kewaunee Scientific Corporation (NASDAQ:KEQU) ("Kewaunee") on behalf of the company's shareholders. The investigation seeks to determine whether Kewaunee and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to the company's investors in connection with recent corporate actions.